These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 16465935)

  • 21. Australian childhood immunisation coverage, 1 April 2015 to 31 March 2016 cohort, assessed as at 30 June 2016.
    Hendry AJ
    Commun Dis Intell Q Rep; 2016 Dec; 40(4):E552-E553. PubMed ID: 28043231
    [No Abstract]   [Full Text] [Related]  

  • 22. Australian childhood immunisation coverage, 1 October to 31 December cohort, assessed as at 31 March 2013.
    Hull B;
    Commun Dis Intell Q Rep; 2013 Sep; 37(3):E276-7. PubMed ID: 24890966
    [No Abstract]   [Full Text] [Related]  

  • 23. Surveillance of adverse events following immunisation in Australia annual report, 2017.
    Dey A; Wang H; Quinn H; Hiam R; Wood N; Beard F; Macartney K
    Commun Dis Intell (2018); 2019 Jul; 43():. PubMed ID: 31315166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surveillance of adverse events following immunisation in Australia, 2012.
    Mahajan D; Dey A; Cook J; Harvey B; Menzies RI; Macartney KM
    Commun Dis Intell Q Rep; 2014 Sep; 38(3):E232-46. PubMed ID: 25391415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2003 to 2006.
    Menzies R; Turnour C; Chiu C; McIntyre P
    Commun Dis Intell Q Rep; 2008 Jun; 32 Suppl():S2-67. PubMed ID: 18711998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Australian childhood immunisation coverage, 1 October to 30 September cohort, assessed as at 31 December 2015.
    Hendry A
    Commun Dis Intell Q Rep; 2016 Jun; 40(2):E304-5. PubMed ID: 27522141
    [No Abstract]   [Full Text] [Related]  

  • 27. Surveillance of adverse events following immunisation in Australia: annual report, 2018.
    Dey A; Wang H; Quinn H; Pillsbury A; Glover C; Hickie M; Wood N; Beard F; Macartney K
    Commun Dis Intell (2018); 2020 Mar; 44():. PubMed ID: 32178607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Supplementary report: surveillance of adverse events following immunisation among children aged < 7 years in Australia, 1 January to 30 June 2008.
    Lawrence GL; Mahajan D; Roomiani I
    Commun Dis Intell Q Rep; 2009 Mar; 33(1):27-31. PubMed ID: 19618765
    [No Abstract]   [Full Text] [Related]  

  • 29. Surveillance of adverse events following immunization: 10 years' experience in Oman.
    Al Awaidy S; Bawikar S; Prakash KR; Al Rawahi B; Mohammed AJ
    East Mediterr Health J; 2010 May; 16(5):474-80. PubMed ID: 20799545
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunisation in general practice. Results from the Australian Morbidity and Treatment Survey, 1990-1991.
    Traynor V; Britt H; Bridges-Webb C; Sayer GP; Meza RA; Charles J
    Aust Fam Physician; 1996 Mar; 25(3):355-9. PubMed ID: 8867187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaccine preventable diseases and vaccination coverage in Australia, 1993-1998.
    McIntyre P; Amin J; Gidding H; Hull B; Torvaldsen S; Tucker A; Turnbull F; Burgess M
    Commun Dis Intell; 2000 Jun; Suppl():v-83. PubMed ID: 12049363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccine preventable diseases and vaccination coverage in Australia, 2003 to 2005.
    Brotherton J; Wang H; Schaffer A; Quinn H; Menzies R; Hull B; Lawrence G; Wood J; Wood N; Rosewell A; Newall A; MacIntyre R; Macartney K; Gidding H; McIntyre P; Booy R
    Commun Dis Intell Q Rep; 2007 Jun; 31 Suppl():S1-152. PubMed ID: 17844780
    [No Abstract]   [Full Text] [Related]  

  • 33. Australian childhood immunisation coverage, 1 January to 31 March cohort, assessed as at 30 June 2013.
    Hull BP
    Commun Dis Intell Q Rep; 2013 Dec; 37(4):E434-5. PubMed ID: 24882242
    [No Abstract]   [Full Text] [Related]  

  • 34. Reporting of communicable disease conditions under surveillance by the APSU, 1 January to 30 June 2004.
    Elliott E; Rose D;
    Commun Dis Intell Q Rep; 2004; 28(4):529-31. PubMed ID: 15745405
    [No Abstract]   [Full Text] [Related]  

  • 35. NSW Annual Adverse Events Following Immunisation Report, 2009.
    Mahajan D; Campbell-Lloyd S; Roomiani I; Menzies RI
    N S W Public Health Bull; 2010; 21(9-10):224-33. PubMed ID: 21211475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Over a Third of Young Children in Michigan Are Susceptible to Vaccine Preventable Diseases.
    Bramer C
    Mich Med; 2016; 115(2):8-9. PubMed ID: 27149752
    [No Abstract]   [Full Text] [Related]  

  • 37. [A special immunization clinic tailors vaccinations].
    Aronsson B; Blennow M
    Lakartidningen; 2008 May 28-Jun 3; 105(22):1675-9. PubMed ID: 18590010
    [No Abstract]   [Full Text] [Related]  

  • 38. Australian childhood immunisation coverage, 1 April to 30 June cohort, assessed as at 30 September 2013.
    Hull B;
    Commun Dis Intell Q Rep; 2014 Mar; 38(1):E85-6. PubMed ID: 25409360
    [No Abstract]   [Full Text] [Related]  

  • 39. Survey of national immunization programs and vaccine coverage rates in Asia Pacific countries.
    Lu CY; Santosham M;
    Vaccine; 2012 Mar; 30(13):2250-5. PubMed ID: 22075085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reporting of communicable disease conditions under surveillance by the APSU, 1 January to 30 September 2003.
    Elliott E; Rose D;
    Commun Dis Intell Q Rep; 2004; 28(1):90-1. PubMed ID: 15072162
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.